These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 3723235

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Aluminum removal with hemodialysis, hemofiltration and charcoal hemoperfusion in uremic patients after desferrioxamine infusion. A comparison of efficiency.
    Weiss LG, Danielson BG, Fellström B, Wikström B.
    Nephron; 1989; 51(3):325-9. PubMed ID: 2918944
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Frequency of adynamic bone disease and aluminum storage in Italian uraemic patients--retrospective analysis of 1429 iliac crest biopsies.
    Ballanti P, Wedard BM, Bonucci E.
    Nephrol Dial Transplant; 1996 Apr; 11(4):663-7. PubMed ID: 8671855
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Clinical and histological results of long-term management of aluminium overloading in uraemic patients with desferrioxamine.
    Canavese C, Pacitti A, Segoloni G, Thea A, D'Amicone M, Stratta P, Rossi P, Sabbioni E, Pietra R, Constantini S.
    J Trace Elem Electrolytes Health Dis; 1989 Mar; 3(1):17-23. PubMed ID: 2535315
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Use of alkaline calcium salts as phosphate binder in uremic patients.
    Fournier A, Morinière P, Ben Hamida F, el Esjer N, Shenovda M, Ghazali A, Bouzernidj M, Achard JM, Westeel PF.
    Kidney Int Suppl; 1992 Oct; 38():S50-61. PubMed ID: 1405382
    [Abstract] [Full Text] [Related]

  • 34. Aluminum removal after chronic intoxication in rats.
    Giordano R, Ioppolo A, Ciaralli L, Rubbiani M, Vernillo I, Costantini S.
    Res Commun Chem Pathol Pharmacol; 1989 Jan; 63(1):119-27. PubMed ID: 2916077
    [Abstract] [Full Text] [Related]

  • 35. Improvement of anemia with deferoxamine in hemodialysis patients with aluminum-induced bone disease.
    Tielemans C, Collart F, Wens R, Smeyers-Verbeeke J, van Hooff I, Dratwa M, Verbeelen D.
    Clin Nephrol; 1985 Nov; 24(5):237-41. PubMed ID: 4075595
    [Abstract] [Full Text] [Related]

  • 36. Editorial: Fluoride and bone disease in uremia.
    Rao TK, Friedman EA.
    Kidney Int; 1975 Mar; 7(3):125-9. PubMed ID: 1123888
    [No Abstract] [Full Text] [Related]

  • 37. Hypogammaglobulinemia in uremic infants receiving peritoneal dialysis.
    Katz A, Kashtan CE, Greenberg LJ, Shapiro RS, Nevins TE, Kim Y.
    J Pediatr; 1990 Aug; 117(2 Pt 1):258-61. PubMed ID: 2380827
    [No Abstract] [Full Text] [Related]

  • 38. Aluminium-related bone disease and haemodialysis.
    Seyfert UT, Didion K, Albert FW.
    Lancet; 1987 Aug 22; 2(8556):456. PubMed ID: 2887758
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.